Prospective Observational Study and Biobank CKIO
NCT04440722 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-03-21
Summary
Prospective observational study and biobank in all persons referred to CKIO
* Patient involvement and quality of life
* Population characteristics regarding hormone levels, safety parameters and clinical outcome before and after gender affirming hormone treatment.
Conditions
- Transgender
Sponsors & Collaborators
-
Odense University Hospital
lead OTHER
Principal Investigators
-
Marianne Andersen, Professor · Odense University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2040-08-01
- Completion
- 2040-08-01
Countries
- Denmark
Study Locations
More Related Trials
-
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
NCT04478760 ·Status: COMPLETED
-
Androgen Effects on the Reproductive Neuroendocrine Axis
NCT06450405 ·Status: TERMINATED ·Phase: PHASE4
-
Testosterone and Its Metabolites in GID
NCT00146146 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hormone Therapy on Renal Function
NCT04482920 ·Status: COMPLETED
-
GEnder Dysphoria Treatment in Sweden
NCT02518009 ·Status: COMPLETED
-
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
NCT07092527 ·Status: RECRUITING ·Phase: PHASE4
-
Transgender In Transition
NCT04028219 ·Status: RECRUITING
-
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
NCT04254354 ·Status: RECRUITING
-
Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
NCT02550431 ·Status: COMPLETED
-
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men
NCT04237467 ·Status: COMPLETED
-
Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More
NCT06053138 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
NCT02667561 ·Status: WITHDRAWN ·Phase: PHASE1
-
Odense Androgen Study in the Elderly
NCT00155961 ·Status: COMPLETED
-
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
NCT00134745 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Testosterone Treatment on Drug Metabolism and Transport
NCT05116293 ·Status: COMPLETED
-
Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
NCT00144404 ·Status: WITHDRAWN
-
TDSM- Testosterone Dose Response in Surgically Menopausal Women
NCT00494208 ·Status: COMPLETED ·Phase: NA
-
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
NCT04515472 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy
NCT06733415 ·Status: ENROLLING_BY_INVITATION
-
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
NCT02434562 ·Status: COMPLETED
-
Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
NCT00700024 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis
NCT05487794 ·Status: COMPLETED ·Phase: NA
-
Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 ·Status: COMPLETED ·Phase: PHASE1
-
Pubertal Induction in Individuals With Hypogonadism
NCT02871986 ·Status: UNKNOWN
-
Subcutaneous Testosterone Project
NCT02229617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2